Posted in | News | Petrochemicals

SABIC and ExxonMobil Reach an Agreement Regarding Polyethylene Technology

Sep 29 2006

Related Stories

The Saudi Basic Industries Corporation (SABIC) announces that it has reached a full and final settlement of its disputes with ExxonMobil arising from technology and patent that can be used in the production of polyethylene. Pursuant to the settlement, SABIC and its worldwide affiliates will have the right to use the technology royalties -free and will equally share in any third-party royalties from the past or future licensing of the technology by ExxonMobil.

All disputes and litigations between SABIC and its partner ExxonMobil have thus been fully and finally settled.

The partners value their long-term business relationship and will continue to focus on their successful ventures in the Kingdom and to explore opportunities to expand on that success.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback